Notify me when Canaan XI L.P. files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| TYRA | Tyra Biosciences, Inc. | COMMON STOCK, $0.0001 PAR VALUE PER SHARE | 7.4% | $29,700,073 | 3,731,165 | Canaan XI L.P. | 31 Dec 2024 | ||
| AEVA | AEVA TECHNOLOGIES, INC. | Common Stock, par value $0.0001 per share | 6.5% | $48,703,908 | 3,597,039 | Canaan XI L.P. | 16 Jun 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|